The KarmaCare™ COVID-19 IgM/IgG is an immunochromatographic lateral flow assay intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, the virus that causes COVID-19.  The test detects antibodies to SARS-CoV-2 in human serum, plasma, venous whole blood, or finger stick whole blood indicating prior infection, even if that person never showed any symptoms.

The KarmaCare™ COVID-19 MDx RT-PCR is a real-time test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasopharyngeal, oropharyngeal and nasal swabs, and nasopharyngeal wash/aspirate) and bronchoalveolar lavage from individuals suspected of COVID-19 by their healthcare provider.

Available for use with the following laboratory systems:

CFX96 Touch™ system (Bio-Rad Laboratories, Inc.)

Applied Biosystems 7500/7500 Fast Real-Time PCR System(Thermofisher Scientific)

The KarmaCare™ COVID-19 Antigen test is authorized for use using nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.  As an intended point-of-care (POC) designated test with a 10 min processing time,KarmaCare™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.

This product is available for Non-US customers only.